腸道疾病檢測市場報告：2030 年趨勢、預測與競爭分析

腸道疾病檢測的趨勢與預測

預計到 2030 年，全球腸道疾病檢測市場將達到約 51 億美元，2024 年至 2030 年複合年成長率為 3.5%。該市場的主要驅動力是腸道疾病檢測設備的不斷創新和技術進步，對樣本利用率的日益關注，以及更快、更有效率、更便宜的計算硬體的興起以及更好的網路連接。全球腸道疾病檢測市場的未來看起來充滿希望，水和食品市場也充滿機會。

Lucintel 預測，由於食品食品腸道疾病發病率的增加，傳統檢測在預測期內仍將是最大的部分。

由於腸道疾病發病率不斷增加，以及為提高對該地區腸道疾病可用性的認知而加大的監管力度，北美似乎將在預測期內繼續成為最大的細分市場。

腸道疾病檢測市場新趨勢

技術進步、不斷變化的醫療保健需求以及對食品安全的日益關注推動了腸道疾病檢測市場的新興趨勢。這些趨勢正在塑造市場動態並影響新測試方法和途徑的發展。

• 分子診斷的整合：分子診斷在病原體檢測中提供高靈敏度和特異性，從而實現更快、更準確的結果。這一趨勢正在透過縮短交付時間和提高檢測能力來提高腸道疾病檢測的效率。隨著這些技術變得更加便宜，它們的採用預計會增加，並在臨床和現場環境中得到更廣泛的應用。
• 開發快速檢測解決方案快速檢測可提供快速結果以實現及時診斷，這對於快速治療至關重要。這一趨勢正在縮小快速回應緊急情況和偏遠地區測試請求的差距。易於獲得的快速檢測的存在可以幫助改善疾病管理，並透過在疫情爆發期間即時做出反應來減輕衛生系統的負擔。
• 利用人工智慧和機器學習：利用人工智慧和機器學習進行巨量資料分析，透過識別傳統手段無法看到的模式來提高診斷準確性。在預測事件發生並設計個人化治療方法的同時，治療過程變得更有效率。人工智慧的使用有望提供更準確、更可行的見解，從而徹底改變疾病監測和管理。
• 專注於食品安全和預防：即將檢測解決方案整合到食品生產和分銷過程中，以防止污染。對食品安全的關注可以在腸道病原體到達消費者之前及早識別和遏制它們。因此，預防性方法催生了新的檢測技術，減少了患有食源性疾病的人數並改善了公共衛生。
• 擴大新興市場的檢測基礎設施：擴大新興市場的檢測基礎設施將解決獲得醫療保健的不平等並支持疾病監測。對診斷工具和檢測設施的投資有助於高負擔地區檢測、管理和控制腸道疾病。這樣的方向不僅可以提高全球衛生公平性，還可以更好地管理弱勢社區的疫情。

分子診斷、快速檢測、人工智慧融入食品安全通訊協定以及基礎設施進步等新興趨勢正在改變腸道疾病檢測市場。他們正在推動檢測技術的進步，提高全球醫療保健服務系統各級的檢測準確性，並完善針對疾病爆發的全球應對策略。

腸道疾病檢測市場近期趨勢

腸道疾病檢測市場的最新趨勢是由技術進步、對食品安全的日益關注以及不斷變化的醫療保健需求所推動的。這些發展的結果是提高診斷準確性、提高檢測速度和整體疾病管理。

• 先進的分子診斷工具簡介：這些工具在檢測腸道病原體方面表現出高靈敏度和特異性，縮短了診斷時間。它還可以更輕鬆地追蹤疫情並制定個人化的治療計劃。採用此類技術將透過提高效率和可靠性來改善臨床實踐和公共衛生部門。
• 快速檢測平台的發展：快速檢測平台的即時對於快速診斷和治療所需的結論性結果至關重要。這些進步將加強對疫情的快速反應和病例的有效管理。快速檢測的可用性改善了檢測的機會，特別是在偏遠和服務不足的地區。
• 擴大新興市場的檢測能力：擴大新興市場的檢測能力：擴大新興市場的檢測能力可解決疾病監測和獲得醫療保健方面的差距。這項進展正在改善疾病負擔高的地區腸道疾病的檢測和管理。它還透過減少疫情的發生來支持全球衛生努力。
• 數位醫療技術的整合：數位醫療技術將提高診斷準確性，同時也有利於疾病爆發的即時監測。人工智慧和資料分析使決策變得更加容易，從而可以提供疫情爆發的早期預警徵兆。這種整合簡化了診斷過程並提高了疾病管理的整體有效性。
• 重視食品安全措施：改善食品安全措施有助於防止污染並降低食源性疾病的風險。這些措施在食品生產和分銷中實施，以確保產品安全。這項進展透過減少與食品相關的腸道疾病而改善了公共衛生。

腸道疾病檢測市場的最新開拓包括提高診斷能力、加強檢測基礎設施以及整合先進技術。這些將加強疾病控制、疫情應對並改善整體公共衛生。

腸道疾病檢測市場的策略性成長機會

技術進步和對公共衛生的日益關注正在為腸道疾病檢測市場的各個應用領域創造策略性成長機會。識別這些成長機會使公司能夠解決成長和創新的關鍵領域。

• 擴大就地檢驗：照護現場有助於快速診斷並實現治療。因此，公司可以開發和銷售易於在臨床環境和現場使用的檢測套組。更重要的是，擴大即時檢測可以改善獲得診斷服務的機會，特別是在資源有限的偏遠地區。
• 多重檢測的開發：多重檢測的使用可以在一次測試中同時檢測多種腸道病原體，從而提高效率並減少診斷感染所需的時間。這項技術進步創建了一個全面監測疾病爆發的系統，同時也有助於識別合併感染。對於從事多重檢測的公司來說，有一個龐大的市場，因為它們提供了比競爭產品更通用、更有效率的測試方法。
• 人工智慧和機器學習的結合：人工智慧和機器學習的結合可以透過分析大型資料集和疫情預測來提高診斷準確性。因此，這種整合將實現更複雜和及時的檢測，透過提供可能影響人類和動物的疾病的早期預警來提高檢測的整體有效性。投資這些技術的公司也可以成為與各類感染疾病相關的監測和管理應用現代化的領導者。
• 專注於食品安全檢測：更好的食品安全檢測可以防止污染並降低食物中毒的風險。開發改進的食源性病原體分離解決方案將增加公共衛生效益，並有助於解決公眾日益成長的擔憂。這為市場相關人員提供了一個絕佳的投資機會，以確保人們不會對所吃的任何東西上癮。
• 拓展新興市場：新興市場因其不斷成長的醫療需求和發達的基礎設施而成為市場開拓的理想地點。透過擴展到這些地區，公司可以進入開拓的市場，並為更好的疾病管理和監測做出貢獻。此舉將建立全球健康舉措並擴大市場範圍。

腸道疾病檢測市場的策略性成長機會包括擴大就地檢驗、開拓多重檢測、整合人工智慧、專注於食品安全以及進入新興市場。這些機會為創新和市場擴張提供了途徑，以滿足關鍵的醫療保健需求並加強疾病管理。

腸道疾病檢測市場的促進因素與挑戰

腸道疾病檢測市場受到許多市場促進因素和挑戰的影響，例如技術進步、經濟狀況和監管條件。分析這些因素有助於相關人員了解動態市場並做出明智的決策。

推動腸道疾病檢測市場的因素包括：

1.技術進步：技術進步：技術進步提高了腸道疾病檢測的準確性、速度和效率。 PCR、NGS 和多重檢測等技術創新提高了檢測能力並縮短了交付時間。由於需求的增加，這些進步將有助於及時、準確的診斷市場的擴大。

2.食品安全問題日益嚴重：食品安全問題日益嚴重，推動了對先進檢測解決方案的需求。因此，食品安全法規變得更加嚴格，並且需要用於測試目的的新技術。為了應對這一趨勢，公司正在投資檢測受污染食品並降低疫情爆發風險的產品線。

3.腸道疾病盛行率不斷上升：腸道疾病盛行率不斷上升，增加了對有效診斷測試的需求。這項促進因素將刺激新型診斷平台的出現並擴大測試基礎設施，從而刺激市場成長。隨著負擔的增加，需要創造性的檢測機制，醫療保健投資也會增加。

4.增加對醫療基礎設施的投資：對醫療基礎設施的投資，特別是在新興市場，將改善疾病監測並建立檢測能力。這將透過增加診斷工具的獲取和改善整體疾病管理來推動市場成長。加強基礎設施將能夠引入先進的檢測技術系統，從而改善健康結果。

腸道疾病檢測市場面臨的挑戰包括：

1. 監管和合規問題：對於製造商來說，診斷測試的開發和核准可能很複雜，因為監管挑戰會增加成本。他們必須滿足監管要求並應對標準的變化。實現市場准入和確保產品品質既需要合規性，但也構成了嚴重的障礙。

2. 供應鏈中斷：供應鏈中斷可能導致製造延遲和診斷測試成本更高。企業需要製定策略來管理供應鏈風險並保持原料的穩定供應。如果您需要維持生產計劃並滿足市場需求，解決供應鏈限制至關重要。

3. 先進技術高成本：分子診斷和多重檢測等先進技術的成本可能難以大規模使用。高價格可能會限制測試解決方案的採用，尤其是在資源匱乏的地區。為了應對這項挑戰，公司必須尋找降低創新價格的方法，同時提高其可用性。

技術進步、食品安全問題日益嚴重、疾病盛行率上升、醫療基礎設施投資、政府政策等是影響腸道疾病檢測產業的主要驅動和阻礙因素因素。監管問題、高成本和供應鏈中斷等挑戰也正在影響市場。了解這些因素將有助於相關人員駕馭市場並發現成長和創新的機會。

腸道疾病檢測的細分

該研究包括按技術、最終用途和地區對全球腸道疾病檢測的預測。

國家腸道疾病檢測市場展望

由於人們對食源性疾病的認知不斷提高、技術進步以及公共衛生優先事項的變化，腸道疾病檢測市場近年來取得了重大進展。改進的診斷方法、提高的測試準確性和快速的結果變得越來越重要。這是需要更好地管理疾病和應對疫情爆發的結果。這些變化的速度將根據每個主要市場（例如美國、中國、德國、印度和日本）的醫療基礎設施、疾病流行和法規環境而有所不同。

• 中國 由於對診斷技術和基礎設施的巨額投資，中國腸道疾病檢測市場正在快速成長。這需要開發能夠處理大量測試的高通量自動化系統，這與日益增加的食品安全問題和不斷增加的人口密度有關。此外，中國政府正在資助研究和開發，以提高食品安全標準並應對疫情。此外，將人工智慧和機器學習納入診斷過程可以提高腸道疾病檢測的效率和準確性。
• 德國：德國透過改善分子診斷和法規結構，在腸道疾病檢測方面做出了巨大努力。該國致力於提高測試準確性，同時透過同時檢測多種病原體的多重檢測等創新來縮短診斷時間。此外，德國正在透過將先進的資料分析和數位平台整合到測試程序中來發展公共衛生應對能力。這些發展符合德國對食品安全管理和疾病預防高標準的承諾。
• 印度：印度腸道疾病診斷的最新趨勢是採用更便宜、更容易取得的診斷工具，例如快速抗原檢測和方便的分子測定。透過努力加強農村和服務不足人口的檢測基礎設施，疾病監測和控制正在改善。與世界各地的組織和政府的夥伴關係重點是改善資料收集和擴大測試能力。這些進展是對因衛生條件差和食品安全問題導致腸道疾病病例數量不斷增加的回應。
• 日本：技術進步和對預防保健的日益重視正在推動日本腸道疾病檢測市場的成長。在日本，PCR和生物感測器等先進診斷技術的使用正在取得進展，以便更準確地檢測引起腸道感染疾病的病原微生物。日本正投入資金進行研究，開發新的測試方法，同時增強現有的測試方法。我們也正在努力整合國家衛生監測系統和檢測解決方案，以不僅加強疫情檢測，而且提高應對能力。

常問問題

Q.1 腸道疾病檢測的市場規模有多大？

A1. 到 2030 年，全球腸道疾病檢測市場預計將達到 51 億美元。

Q.2 腸道疾病檢測市場的成長預測如何？

A2. 2024年至2030年，全球腸道疾病檢測市場預計將以3.5%的複合年成長率成長。

Q.3 影響腸道疾病檢測市場成長的關鍵促進因素有哪些？

A3. 該市場的主要驅動力是腸道疾病檢測設備的創新和技術進步，對樣本利用率的日益關注，更快、更熟練和更便宜的計算技術以及更好的網路連接。

Q4.市場的主要細分市場是：

A4. 全球腸道疾病檢測市場前景廣闊，水和食品市場充滿機會。

Q5.市場的主要企業是：

A5. 主要腸道疾病檢測公司如下：

• Merck
• Thermo Fisher Scientific
• SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• PerkinElmer
• Becton Dickinson

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預測，由於對食品的需求增加以及腸道疾病發病率的增加，傳統檢測在預測期內仍將是最大的部分。

Q7. 未來五年預計哪些地區的市場成長最快？

A7. 由於腸道疾病發生率不斷上升，以及為提高人們對腸道疾病的認知而加大的監管力度，北美地區將在預測期內繼續成長。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章 全球腸道疾病檢測市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

• 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
• 全球腸道疾病檢測市場趨勢（2018-2023）與預測（2024-2030）
• 按技術分類的全球腸道疾病檢測市場
  • 傳統的
  • 迅速地
  • 強調便利性
  • 聚合酵素鏈鎖反應
  • 免疫檢測
  • 層析法和光譜
• 全球腸道疾病檢測市場（依最終用途）
  • 食品
  • 水

第4章 2018-2030年區域市場趨勢及預測分析

• 全球腸道疾病檢測市場按地區分類
• 北美腸道疾病檢測市場
• 歐洲腸道疾病檢測市場
• 亞太腸道疾病檢測市場
• 其他區域性腸道疾病檢測市場

第5章 競爭分析

• 產品系列分析
• 業務整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球腸道疾病檢測市場的技術成長機會
  • 全球腸道疾病檢測市場最終用途的成長機會
  • 全球腸道疾病檢測市場按地區成長機會
• 全球腸道疾病檢測市場新趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球腸道疾病檢測市場的能力
  • 全球腸道疾病檢測市場的併購與合資
  • 認證和許可

第7章主要企業概況

• Merck
• Thermo Fisher Scientific
  • SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• PerkinElmer
• Becton Dickinson

Enteric Disease Testing Trends and Forecast

The future of the global enteric disease testing market looks promising with opportunities in the water and food markets. The global enteric disease testing market is expected to reach an estimated $5.1 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are rising number of innovations and technological advancements in enteric disease testing devices, increasing focus on sample utilization, and growing advancement for quicker, proficient, and cheaper computing hardware tied with better network connectivity.

Lucintel forecasts that traditional testing will remain the largest segment over the forecast period due to growing demand for processed and convenience food, as well as, increasing incidences of enteric diseases.

North America will remain the largest segment over the forecast period due to the rising incidences of enteric diseases and increasing regulatory efforts for spreading awareness regarding the availability of enteric diseases in this region.

Emerging Trends in the Enteric Disease Testing Market

Emerging trends in the enteric disease testing market are driven by advancements in technology, changing healthcare needs, and increased focus on food safety. These trends are shaping the market dynamics and influencing the development of new testing methodologies and approaches.

• Integration of Molecular Diagnostics: Molecular diagnostics offer high sensitivity and specificity for detecting pathogens, enabling quicker and more accurate results. This trend is improving the efficiency of enteric disease testing by reducing turnaround times and enhancing detection capabilities. As these technologies become more affordable, their adoption is expected to increase, leading to more widespread use in both clinical and field settings.
• Development of Rapid Testing Solutions: Rapid: tests give quick results for timely diagnoses that are important in prompt treatment. This tendency is filling the gap of swiftly responding to testing requirements under emergency conditions as well as at a distance. The presence of easily accessible rapid tests helps improve disease control and lighten health systems' load through instant response during outbreaks.
• Use of Artificial Intelligence and Machine Learning: Big data analysis by AI and machine learning enhances diagnostic precision by recognizing patterns which would otherwise not be seen using traditional means. Testing processes are made more efficient while predicting outbreaks and designing personalized treatment approaches. More accurate and actionable insights are expected to be provided through the use AI, thus revolutionizing disease surveillance and management.
• Emphasis on Food Safety and Prevention: This is about integrating testing solutions into food production and distribution processes for the purpose of preventing contamination. An increased focus on food safety aids in early identification and containment of enteric pathogens before they reach consumers. As a result, preventive approaches have given rise to new testing technologies and reduced the rate at which people suffer from foodborne diseases thereby improving public health.
• Expansion of Testing Infrastructure in Emerging Markets: Expanding the testing infrastructure in emerging countries addresses gaps in access to healthcare and aids disease surveillance. The investments made towards diagnostic tools and testing facilities are helping detect, manage, and control enteric diseases in areas with high disease burden. This direction is enhancing global health fairness as well as enabling better outbreak management among underprivileged communities.

These emerging trends molecular diagnostics, rapid tests, AI incorporated into food safety protocols, advancing infrastructures are transforming the market for enteric disease tests. They are propelling technological advancements in detection techniques, improving test accuracy rates at all levels of healthcare delivery systems globally as well as refining worldwide response strategies against ailment outbreaks.

Recent Developments in the Enteric Disease Testing Market

Recent developments in the enteric disease testing market have been driven by technological advancements, increased focus on food safety and changing healthcare needs. Improved diagnostic accuracy, testing speed, and overall disease management are a result of these developments.

• Introduction of Advanced Molecular Diagnostic Tools: These tools show high degree of sensitivity and specificity to detect enteric pathogens hence reducing time taken to diagnose them. They allow better tracking of outbreaks as well as personalized treatments plans. Through such technologies adoption, efficiency and reliability will be boosted thus improving both clinical settings and also public health sectors.
• Growth of Rapid Testing Platforms: The immediacy of rapid testing platforms is vital in getting conclusive results, which are necessary for immediate diagnosis and treatment. Such an advancement enhances quick response to outbreaks and effective management of cases. Rapid tests availability has improved access to testing particularly in remote and underserved areas.
• Expansion of Testing Capabilities in Emerging Markets: Expansion of Testing Capabilities in Emerging Markets addresses gaps in disease surveillance and healthcare access. This development is improving the detection and management of enteric diseases in regions with high disease burden. It also supports global health efforts by reducing the incidence of outbreaks.
• Integration of Digital Health Technologies: Diagnostic accuracy can be enhanced through digital health technologies while at the same time facilitating real-time monitoring on disease outbreaks. AI and data analytics have facilitated decision making thereby predicting early outbreak signs. With this integration, the diagnostic process has been made simpler thereby enhancing overall effectiveness for managing diseases
• Increased Emphasis on Food Safety Measures: Improved food safety measures help prevent contamination and reduce the risk of foodborne illnesses. These are implemented in food production and distribution to ensure safe products. This advancement has resulted in better public health outcomes through reducing enteric diseases associated with food.

Latest developments around enteric disease testing market include; improving diagnostic capabilities, enhanced testing infrastructure, and integration of advanced technologies. They enhance disease control, reaction to outbreaks as well as enhance overall public wellness.

Strategic Growth Opportunities for Enteric Disease Testing Market

Advancements in technology and growing emphasis on public health have created strategic growth opportunities within different application domains in the enteric disease testing market. Identifying these opportunities allows companies to address key areas for growth and innovation.

• Expansion of Point-of-Care Testing: Tests at the point of care, can help in quick diagnostics and make treatment possible. As a result, companies can develop and sell testing kits that are easy to use in both clinical and field settings. More importantly, expanding point-of- care testing may improve access to diagnostic services especially in remote areas with limited resources.
• Development of Multiplex Assays: The use of multiplex assays enables the simultaneous detection of many enteric pathogens in one test which increases efficiency and decreases the time required to diagnose infection. This technological advancement provides for an all-inclusive monitoring system for disease prevalence while helping to identify co-infections. There is a very big market for companies that deal with multiplex assays because they offer a more versatile as well as efficient way of doing tests than their competitor products.
• Integration of AI and Machine Learning: AI together with machine learning can enhance accuracy in diagnoses through analyzing large data sets as well as predicting outbreaks. Consequently, this integration allows better refined as well as timely detections thereby improving overall effectiveness of examinations by giving early warning signs on diseases that may affect humans or animals alike. Such firms investing on these technologies can be leaders regarding modernization even when it comes to surveillance and management applications related to different types infectious diseases.
• Focus on Food Safety Testing: Better food safety testing prevents contamination and decreases the danger of food poisoning. The development of improved solutions for foodborne pathogen isolation can help increase public health benefits and address the increasing concerns of the masses. This provides an incredible chance for market players to invest in ensuring that people are not poisoning themselves with whatever they eat.
• Expansion into Emerging Markets: A number of medical needs that are growing as well as infrastructure being developed that makes emerging markets good places for expansion. By going into these regions, companies can reach out to untapped markets where they contribute towards better disease management and surveillance. Such a move establishes global health initiatives and extends market coverage.

Strategic growth opportunities in the enteric disease testing market include expanding point-of-care testing, developing multiplex assays, integrating AI, focusing on food safety, and entering emerging markets. These opportunities offer avenues for innovation and market expansion, addressing critical healthcare needs and enhancing disease management.

Enteric Disease Testing Market Driver and Challenges

The enteric disorder examination market is influenced by a number of drivers and challenges, such as technological advancement, economic situation, and regulatory conditions. Analyzing these factors helps stakeholders to understand the dynamic market and make informed decisions.

The factors responsible for driving the enteric disease testing market include:

1. Technological Advancements: Technological improvements increase the accuracy, speed and efficiency of enteric disease testing. Innovations like PCR, NGS and multiplex assays improve detection abilities and shorten turnaround times. These advances help expand the market for accurate diagnostics that are timely due to increased demand.

2. Growing Food Safety Concerns: The increasing concerns pertaining to food safety are driving the demand for advanced testing solutions. This driver prompts new technologies for testing purposes while tightening regulations on food safety. In response to this trend, businesses invest in product lines that detect contaminated foods thus mitigating any danger of outbreaks.

3. Rising Prevalence of Enteric Diseases: A rise in the prevalence of enteric diseases increases the demand for effective diagnostic tests. This driver stimulates market growth by encouraging emergence of novel diagnostic platforms and expands testing infrastructure. As the burden grows, there is need for creative testing mechanisms and increased investment in health care.

4. Increased Healthcare Infrastructure Investment: Investments in healthcare infrastructure particularly in emerging markets, improve disease surveillance and test capacity building. This driver increases access to diagnostics tools and improves general management of diseases thereby supporting market growth. Enhanced infrastructure allows for the installation of sophisticated testing technology systems leading to better health outcomes.

Challenges in the enteric disease testing market are:

1. Regulatory and Compliance Issues: The development and approval of diagnostic tests could be complicated for manufacturers by the regulatory challenges that raise costs. Regulatory requirements must be met and changes in standards adapted to. Achieving market entry and ensuring product quality both require compliance, but it also acts as a serious barrier.

2. Supply Chain Disruptions: Manufacturing delays and higher costs of diagnostic testing can result from supply chain disruptions. Companies need to come up with strategies to manage supply chain risks and maintain steady supplies of materials. Dealing with supply chain constraints is crucial when production timetables need to be maintained and market demands are supposed to be fulfilled.

3. High Costs of Advanced Technologies: The expense incurred in advanced technologies such as molecular diagnostics, multiplex assays may make them unaffordable at large scale use. High price tags may limit the reach of testing solutions especially in poorly endowed locations with resources. In order to deal with this challenge, companies must look for ways to decrease the price tag on their innovations as well as increase their availability.

Technological advances, increased worries about food safety, increased disease prevalence, investment in health infrastructure and government policies are the key drivers and constraints impacting the enteric disease testing industry. Also affecting the market are challenges like regulatory concerns, high costs, supply chain disruption. Understanding these factors helps stakeholders navigate the market and identify opportunities for growth and innovation.

List of Enteric Disease Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies enteric disease testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the enteric disease testing companies profiled in this report include-

• Merck
• Thermo Fisher Scientific
• SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• Perkinelmer
• Becton Dickinson

Enteric Disease Testing by Segment

The study includes a forecast for the global enteric disease testing by technology, end use, and region.

Enteric Disease Testing Market by Technology [Analysis by Value from 2018 to 2030]:

• Traditional
• Rapid
• Convenience-Based
• Polymerase Chain Reaction
• Immunoassay
• Chromatography & Spectrometry

Enteric Disease Testing Market by End Use [Analysis by Value from 2018 to 2030]:

• Food
• Water

Enteric Disease Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Enteric Disease Testing Market

The enteric disease testing market has recently witnessed significant advancements due to the increased awareness of foodborne diseases, technological advancements, and change in public health priorities. Improved diagnostics, better testing accuracy and quicker results have become more important. This is as a result of a need to manage diseases better and respond to outbreaks. The rate at which these changes occur differ depending on the healthcare infrastructure existing in the respective key markets such as United States, China, Germany, India and Japan along with their regulatory environment besides disease prevalence.

• China: The enteric disease testing market in China is growing fast with huge investments made in diagnostic technology and infrastructure. This necessitates the development of high throughput automated systems that can handle large numbers of tests and are related to higher food safety concerns and increased population density. In addition, the Chinese government is involved in funding research and development to improve food safety standards as well as respond to outbreaks. Furthermore, incorporation of AI and machine learning into diagnostic processes has led to better efficiency and accuracy during enteric disease testing.
• Germany: Germany has made substantial efforts in enteric disease testing through molecular diagnostics and improved regulatory frameworks. The country is focusing on enhancing test accuracy while reducing time to diagnosis through innovations like multiplex assays for simultaneous multiple pathogen detection. In addition, Germany is developing capacities for public health response by integrating advanced data analytics as well as digital platforms into its testing procedures. These developments are consistent with Germany's commitment to high standards in food safety control and prevention of diseases
• India: Recent developments in diagnosing enteric diseases in India have incorporated more affordable and accessible diagnostic tools such as rapid antigen tests and simplified molecular assays. Disease surveillance and management is being improved through attempts to enhance testing infrastructure in rural areas and underserved populations. Global organizations' partnerships with the government are centered on improving data collection and expanding testing capabilities. These advancements are a response to an increase in cases of enteric diseases as a result of poor sanitation, food safety issues among others.
• Japan: Technological advancements and an increasing emphasis on preventive healthcare are driving the growth of Japan's market for enteric disease testing. The nation is increasingly using PCR and biosensors among other advanced diagnostic techniques for better detection of pathogenic organisms that cause enteric infections. To develop new methodologies for examination while enhancing the already existing ones Japan spends money on research. There is also ongoing effort aimed at integrating the national health surveillance systems with the test solutions so that there can be outbreak detection enhancement as well as response capacities improvement too.

Features of the Global Enteric Disease Testing Market

Market Size Estimates: Enteric disease testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Enteric disease testing market size by technology, end use, and region in terms of value ($B).

Regional Analysis: Enteric disease testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technology, end use, and regions for the enteric disease testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the enteric disease testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the enteric disease testing market size?

Answer: The global enteric disease testing market is expected to reach an estimated $5.1 billion by 2030.

Q.2 What is the growth forecast for enteric disease testing market?

Answer: The global enteric disease testing market is expected to grow with a CAGR of 3.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the enteric disease testing market?

Answer: The major drivers for this market are rising number of innovations and technological advancements in enteric disease testing devices, increasing focus on sample utilization, and growing advancement for quicker, proficient, and cheaper computing hardware tied with better network connectivity.

Q4. What are the major segments for enteric disease testing market?

Answer: The future of the global enteric disease testing market looks promising with opportunities in the water and food markets.

Q5. Who are the key enteric disease testing market companies?

Answer: Some of the key enteric disease testing companies are as follows:

• Merck
• Thermo Fisher Scientific
• SGS
• Eurofins Scientific
• Bureau Veritas
• Intertek
• Romer Labs
• PerkinElmer
• Becton Dickinson

Q6. Which enteric disease testing market segment will be the largest in future?

Answer: Lucintel forecasts that traditional testing will remain the largest segment over the forecast period due to growing demand for processed and convenience food, as well as, increasing incidences of enteric diseases.

Q7. In enteric disease testing market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to the rising incidences of enteric diseases and increasing regulatory efforts for spreading awareness regarding the availability of enteric diseases in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the enteric disease testing market by technology (traditional, rapid, convenience-based, polymerase chain reaction, immunoassay, and chromatography & spectrometry), end use (food and water), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
• Market Report

Table of Contents

1. Executive Summary

2. Global Enteric Disease Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Enteric Disease Testing Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Enteric Disease Testing Market by Technology
  • 3.3.1: Traditional
  • 3.3.2: Rapid
  • 3.3.3: Convenience-Based
  • 3.3.4: Polymerase Chain Reaction
  • 3.3.5: Immunoassay
  • 3.3.6: Chromatography & Spectrometry
• 3.4: Global Enteric Disease Testing Market by End Use
  • 3.4.1: Food
  • 3.4.2: Water

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Enteric Disease Testing Market by Region
• 4.2: North American Enteric Disease Testing Market
  • 4.2.1: North American Enteric Disease Testing Market by Technology :Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.2.2: North American Enteric Disease Testing Market by End Use: Food and Water
• 4.3: European Enteric Disease Testing Market
  • 4.3.1: European Enteric Disease Testing Market by Technology :Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.3.2: European Enteric Disease Testing Market by End Use: Food and Water
• 4.4: APAC Enteric Disease Testing Market
  • 4.4.1: APAC Enteric Disease Testing Market by Technology : Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.4.2: APAC Enteric Disease Testing Market by End Use: Food and Water
• 4.5: ROW Enteric Disease Testing Market
  • 4.5.1: ROW Enteric Disease Testing Market by Technology : Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction, Immunoassay, and Chromatography & Spectrometry
  • 4.5.2: ROW Enteric Disease Testing Market by End Use: Food and Water

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Enteric Disease Testing Market by Technology
  • 6.1.2: Growth Opportunities for the Global Enteric Disease Testing Market by End Use
  • 6.1.3: Growth Opportunities for the Global Enteric Disease Testing Market by Region
• 6.2: Emerging Trends in the Global Enteric Disease Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Enteric Disease Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Enteric Disease Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Merck
• 7.2: Thermo Fisher Scientific
  • 7.1.1: SGS
• 7.4: Eurofins Scientific
• 7.5: Bureau Veritas
• 7.6: Intertek
• 7.7: Romer Labs
• 7.8: PerkinElmer
• 7.9: Becton Dickinson